14-3-3结合使帕金森病相关激酶LRRK2保持在一个不活跃的状态
bioRxiv : the preprint server for biology
|November 28, 2024
概括
14-3-3蛋白与丰富的白素重复激酶2 (LRRK2) 结合,抑制其活性,这对帕金森病 (PD) 发病至关重要. 这种结构洞察力揭示了LRRK2如何保持休眠状态,并建议新的PD治疗点.
科学领域:
- 分子生物学分子生物学
- 结构生物学 结构生物学
- 神经科学是一个神经科学.
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 与帕金森病 (PD) 病原发生有关.
- 已知14-3-3蛋白是LRRK2活性的调节者.
研究的目的:
- 通过14-3-3蛋白质确定LRRK2自身抑制的结构基础.
- 为了研究帕金森病相关突变对这种相互作用的影响.
主要方法:
- 低温电子显微镜 (cryo-EM) 解析了LRRK2:14-3-3复杂结构.
- 突变发生的研究,以评估突变的功能后果.
主要成果:
- 冷-EM结构显示了一个14-3-3二元体稳定了自身抑制的LRRK2单元体.
- 14-3-3结合发生在酸化部位和Roc-COR子域,限制LRRK2的活性.
- 与PD相关的突变削弱了14-3-3结合,减少了LRRK2的抑制.
结论:
- 这项研究提供了LRRK2自身抑制的结构机制.
- 这些发现揭示了PD生物标记机制,并表明LRRK2-14-3-3相互作用作为PD的治疗点.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Amplifying Signals via Enzymatic Cascade
8.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.3K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Receptor Tyrosine Kinases
12.3K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.3K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K


